课题基金 / 基金详情

CLINICAL TRIAL: A STUDY TO ASSESS THE PROPHYLACTIC EFFICACY/SAFETY OF GD-ALUM/MP

CLINICAL TRIAL: A STUDY TO ASSESS THE PROPHYLACTIC EFFICACY/SAFETY OF GD-ALUM/MP
临床试验：评估 GD-ALUM/MP 预防功效/安全性的研究
批准号：
7950788
负责人：
DAVID BAKER
金额：
$0.02万
依托单位：
STATE UNIVERSITY NEW YORK STONY BROOK
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-12-01 至 2009-11-30
来源：
https://reporter.nih.gov/project-details/7950788
关键词：
Clinical ResearchClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantHealthHumanInfectionInstitutionLifeResearchResearch PersonnelResourcesSafetySimplexvirusSourceUnited States National Institutes of HealthVaccinesVirusaluminum sulfatenovel vaccinespreventprophylactic

项目摘要

项目成果

DAVID BAKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to assess the efficacy and safety of this new vaccine. Herpes is a serious health problem and is the most common infections in humans. It is caused by a herpes simplex virus (HSV). Once infected, the virus stays in your body for your entire life. We are hopeful that this vaccine may prevent the spread of this infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
  • 批准号：
    10460648
  • 项目类别：
  • 资助金额：
    $71.39万
  • 财政年份：
    2021
  • 负责人：
    DAVID BAKER
  • 依托单位：
    UNIVERSITY OF WASHINGTON
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
  • 批准号：
    10296596
  • 项目类别：
  • 资助金额：
    $72.36万
  • 财政年份：
    2021
  • 负责人：
    DAVID BAKER
  • 依托单位：
    UNIVERSITY OF WASHINGTON
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
  • 批准号：
    10672446
  • 项目类别：
  • 资助金额：
    $70.38万
  • 财政年份：
    2021
  • 负责人：
    DAVID BAKER
  • 依托单位：
    UNIVERSITY OF WASHINGTON
Project 4: Novel reagent development to enable molecular characterization
  • 批准号：
    10359195
  • 项目类别：
  • 资助金额：
    $44.88万
  • 财政年份：
    2020
  • 负责人：
    DAVID BAKER
  • 依托单位：
    UNIVERSITY OF WASHINGTON
海外基金